nodes	percent_of_prediction	percent_of_DWPC	metapath
Metronidazole—CYP2C9—Capecitabine—colon cancer	0.179	0.321	CbGbCtD
Metronidazole—CYP2C8—Fluorouracil—colon cancer	0.152	0.273	CbGbCtD
Metronidazole—CYP2C9—Fluorouracil—colon cancer	0.106	0.19	CbGbCtD
Metronidazole—CYP3A4—Irinotecan—colon cancer	0.0642	0.115	CbGbCtD
Metronidazole—CYP3A4—Vincristine—colon cancer	0.0561	0.101	CbGbCtD
Metronidazole—Upper respiratory tract infection—Capecitabine—colon cancer	0.000744	0.00168	CcSEcCtD
Metronidazole—Convulsion—Vincristine—colon cancer	0.000741	0.00167	CcSEcCtD
Metronidazole—Hypertension—Vincristine—colon cancer	0.000739	0.00167	CcSEcCtD
Metronidazole—Loss of consciousness—Irinotecan—colon cancer	0.000732	0.00165	CcSEcCtD
Metronidazole—Photosensitivity reaction—Capecitabine—colon cancer	0.000731	0.00165	CcSEcCtD
Metronidazole—Hypertension—Irinotecan—colon cancer	0.000719	0.00162	CcSEcCtD
Metronidazole—Leukopenia—Fluorouracil—colon cancer	0.000714	0.00161	CcSEcCtD
Metronidazole—Infestation—Capecitabine—colon cancer	0.000714	0.00161	CcSEcCtD
Metronidazole—Infestation NOS—Capecitabine—colon cancer	0.000714	0.00161	CcSEcCtD
Metronidazole—Depression—Capecitabine—colon cancer	0.000712	0.0016	CcSEcCtD
Metronidazole—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000708	0.0016	CcSEcCtD
Metronidazole—Neuropathy peripheral—Capecitabine—colon cancer	0.0007	0.00158	CcSEcCtD
Metronidazole—Anaphylactic shock—Vincristine—colon cancer	0.000698	0.00157	CcSEcCtD
Metronidazole—Oedema—Vincristine—colon cancer	0.000698	0.00157	CcSEcCtD
Metronidazole—Jaundice—Capecitabine—colon cancer	0.000696	0.00157	CcSEcCtD
Metronidazole—Stomatitis—Capecitabine—colon cancer	0.000696	0.00157	CcSEcCtD
Metronidazole—Infection—Vincristine—colon cancer	0.000694	0.00156	CcSEcCtD
Metronidazole—Urinary tract infection—Capecitabine—colon cancer	0.000694	0.00156	CcSEcCtD
Metronidazole—Conjunctivitis—Capecitabine—colon cancer	0.000694	0.00156	CcSEcCtD
Metronidazole—Convulsion—Fluorouracil—colon cancer	0.000691	0.00156	CcSEcCtD
Metronidazole—Osteoarthritis—Methotrexate—colon cancer	0.000689	0.00155	CcSEcCtD
Metronidazole—Confusional state—Irinotecan—colon cancer	0.000686	0.00155	CcSEcCtD
Metronidazole—Nervous system disorder—Vincristine—colon cancer	0.000685	0.00154	CcSEcCtD
Metronidazole—Thrombocytopenia—Vincristine—colon cancer	0.000684	0.00154	CcSEcCtD
Metronidazole—Anaphylactic shock—Irinotecan—colon cancer	0.00068	0.00153	CcSEcCtD
Metronidazole—Oedema—Irinotecan—colon cancer	0.00068	0.00153	CcSEcCtD
Metronidazole—Chest pain—Fluorouracil—colon cancer	0.000679	0.00153	CcSEcCtD
Metronidazole—Infection—Irinotecan—colon cancer	0.000676	0.00152	CcSEcCtD
Metronidazole—Hyperhidrosis—Vincristine—colon cancer	0.000675	0.00152	CcSEcCtD
Metronidazole—Hepatobiliary disease—Capecitabine—colon cancer	0.000675	0.00152	CcSEcCtD
Metronidazole—Shock—Irinotecan—colon cancer	0.000669	0.00151	CcSEcCtD
Metronidazole—Nervous system disorder—Irinotecan—colon cancer	0.000667	0.0015	CcSEcCtD
Metronidazole—Agranulocytosis—Capecitabine—colon cancer	0.000666	0.0015	CcSEcCtD
Metronidazole—Thrombocytopenia—Irinotecan—colon cancer	0.000666	0.0015	CcSEcCtD
Metronidazole—Anorexia—Vincristine—colon cancer	0.000666	0.0015	CcSEcCtD
Metronidazole—Irritability—Methotrexate—colon cancer	0.000658	0.00148	CcSEcCtD
Metronidazole—Hyperhidrosis—Irinotecan—colon cancer	0.000657	0.00148	CcSEcCtD
Metronidazole—Confusional state—Fluorouracil—colon cancer	0.000657	0.00148	CcSEcCtD
Metronidazole—Anaphylactic shock—Fluorouracil—colon cancer	0.000651	0.00147	CcSEcCtD
Metronidazole—Oedema—Fluorouracil—colon cancer	0.000651	0.00147	CcSEcCtD
Metronidazole—Anorexia—Irinotecan—colon cancer	0.000648	0.00146	CcSEcCtD
Metronidazole—Ataxia—Methotrexate—colon cancer	0.000648	0.00146	CcSEcCtD
Metronidazole—Infection—Fluorouracil—colon cancer	0.000647	0.00146	CcSEcCtD
Metronidazole—Rhinitis—Capecitabine—colon cancer	0.000642	0.00145	CcSEcCtD
Metronidazole—Hepatitis—Capecitabine—colon cancer	0.000641	0.00144	CcSEcCtD
Metronidazole—Nervous system disorder—Fluorouracil—colon cancer	0.000639	0.00144	CcSEcCtD
Metronidazole—Thrombocytopenia—Fluorouracil—colon cancer	0.000638	0.00144	CcSEcCtD
Metronidazole—Hypoaesthesia—Capecitabine—colon cancer	0.000637	0.00144	CcSEcCtD
Metronidazole—Liver function test abnormal—Methotrexate—colon cancer	0.000636	0.00144	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Vincristine—colon cancer	0.000636	0.00143	CcSEcCtD
Metronidazole—Pharyngitis—Capecitabine—colon cancer	0.000636	0.00143	CcSEcCtD
Metronidazole—Insomnia—Vincristine—colon cancer	0.000632	0.00142	CcSEcCtD
Metronidazole—Connective tissue disorder—Capecitabine—colon cancer	0.00063	0.00142	CcSEcCtD
Metronidazole—Paraesthesia—Vincristine—colon cancer	0.000627	0.00141	CcSEcCtD
Metronidazole—Breast disorder—Methotrexate—colon cancer	0.000623	0.0014	CcSEcCtD
Metronidazole—Anorexia—Fluorouracil—colon cancer	0.000621	0.0014	CcSEcCtD
Metronidazole—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000621	0.0014	CcSEcCtD
Metronidazole—Visual impairment—Capecitabine—colon cancer	0.000617	0.00139	CcSEcCtD
Metronidazole—Insomnia—Irinotecan—colon cancer	0.000615	0.00139	CcSEcCtD
Metronidazole—Paraesthesia—Irinotecan—colon cancer	0.000611	0.00138	CcSEcCtD
Metronidazole—Decreased appetite—Vincristine—colon cancer	0.000607	0.00137	CcSEcCtD
Metronidazole—Erythema multiforme—Capecitabine—colon cancer	0.000606	0.00137	CcSEcCtD
Metronidazole—Somnolence—Irinotecan—colon cancer	0.000605	0.00136	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Vincristine—colon cancer	0.000603	0.00136	CcSEcCtD
Metronidazole—Fatigue—Vincristine—colon cancer	0.000602	0.00136	CcSEcCtD
Metronidazole—Eye disorder—Capecitabine—colon cancer	0.000599	0.00135	CcSEcCtD
Metronidazole—Dyspepsia—Irinotecan—colon cancer	0.000599	0.00135	CcSEcCtD
Metronidazole—Tinnitus—Capecitabine—colon cancer	0.000597	0.00135	CcSEcCtD
Metronidazole—Pain—Vincristine—colon cancer	0.000597	0.00135	CcSEcCtD
Metronidazole—Constipation—Vincristine—colon cancer	0.000597	0.00135	CcSEcCtD
Metronidazole—Asthma—Methotrexate—colon cancer	0.000596	0.00134	CcSEcCtD
Metronidazole—Cardiac disorder—Capecitabine—colon cancer	0.000595	0.00134	CcSEcCtD
Metronidazole—Flushing—Capecitabine—colon cancer	0.000595	0.00134	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000593	0.00134	CcSEcCtD
Metronidazole—Decreased appetite—Irinotecan—colon cancer	0.000591	0.00133	CcSEcCtD
Metronidazole—Eosinophilia—Methotrexate—colon cancer	0.00059	0.00133	CcSEcCtD
Metronidazole—Insomnia—Fluorouracil—colon cancer	0.000589	0.00133	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Irinotecan—colon cancer	0.000587	0.00132	CcSEcCtD
Metronidazole—Fatigue—Irinotecan—colon cancer	0.000586	0.00132	CcSEcCtD
Metronidazole—Paraesthesia—Fluorouracil—colon cancer	0.000585	0.00132	CcSEcCtD
Metronidazole—Pancreatitis—Methotrexate—colon cancer	0.000584	0.00132	CcSEcCtD
Metronidazole—Pain—Irinotecan—colon cancer	0.000582	0.00131	CcSEcCtD
Metronidazole—Constipation—Irinotecan—colon cancer	0.000582	0.00131	CcSEcCtD
Metronidazole—Angiopathy—Capecitabine—colon cancer	0.000581	0.00131	CcSEcCtD
Metronidazole—Somnolence—Fluorouracil—colon cancer	0.000579	0.00131	CcSEcCtD
Metronidazole—Immune system disorder—Capecitabine—colon cancer	0.000579	0.00131	CcSEcCtD
Metronidazole—Mediastinal disorder—Capecitabine—colon cancer	0.000577	0.0013	CcSEcCtD
Metronidazole—Dyspepsia—Fluorouracil—colon cancer	0.000573	0.00129	CcSEcCtD
Metronidazole—Abdominal discomfort—Methotrexate—colon cancer	0.000571	0.00129	CcSEcCtD
Metronidazole—Gastrointestinal pain—Vincristine—colon cancer	0.000571	0.00129	CcSEcCtD
Metronidazole—Decreased appetite—Fluorouracil—colon cancer	0.000566	0.00128	CcSEcCtD
Metronidazole—Pancytopenia—Methotrexate—colon cancer	0.000566	0.00128	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000562	0.00127	CcSEcCtD
Metronidazole—Mental disorder—Capecitabine—colon cancer	0.000561	0.00127	CcSEcCtD
Metronidazole—Feeling abnormal—Irinotecan—colon cancer	0.00056	0.00126	CcSEcCtD
Metronidazole—Erythema—Capecitabine—colon cancer	0.000558	0.00126	CcSEcCtD
Metronidazole—Dysuria—Methotrexate—colon cancer	0.000557	0.00126	CcSEcCtD
Metronidazole—Neutropenia—Methotrexate—colon cancer	0.000557	0.00126	CcSEcCtD
Metronidazole—Pain—Fluorouracil—colon cancer	0.000557	0.00126	CcSEcCtD
Metronidazole—Gastrointestinal pain—Irinotecan—colon cancer	0.000556	0.00125	CcSEcCtD
Metronidazole—Upper respiratory tract infection—Methotrexate—colon cancer	0.000554	0.00125	CcSEcCtD
Metronidazole—Abdominal pain—Vincristine—colon cancer	0.000552	0.00124	CcSEcCtD
Metronidazole—Body temperature increased—Vincristine—colon cancer	0.000552	0.00124	CcSEcCtD
Metronidazole—Flatulence—Capecitabine—colon cancer	0.00055	0.00124	CcSEcCtD
Metronidazole—Dysgeusia—Capecitabine—colon cancer	0.000546	0.00123	CcSEcCtD
Metronidazole—Photosensitivity reaction—Methotrexate—colon cancer	0.000544	0.00123	CcSEcCtD
Metronidazole—Back pain—Capecitabine—colon cancer	0.000539	0.00122	CcSEcCtD
Metronidazole—Body temperature increased—Irinotecan—colon cancer	0.000538	0.00121	CcSEcCtD
Metronidazole—Abdominal pain—Irinotecan—colon cancer	0.000538	0.00121	CcSEcCtD
Metronidazole—Feeling abnormal—Fluorouracil—colon cancer	0.000537	0.00121	CcSEcCtD
Metronidazole—Muscle spasms—Capecitabine—colon cancer	0.000536	0.00121	CcSEcCtD
Metronidazole—Drowsiness—Methotrexate—colon cancer	0.000531	0.0012	CcSEcCtD
Metronidazole—Infestation NOS—Methotrexate—colon cancer	0.000531	0.0012	CcSEcCtD
Metronidazole—Infestation—Methotrexate—colon cancer	0.000531	0.0012	CcSEcCtD
Metronidazole—Depression—Methotrexate—colon cancer	0.00053	0.00119	CcSEcCtD
Metronidazole—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000527	0.00119	CcSEcCtD
Metronidazole—Vision blurred—Capecitabine—colon cancer	0.000526	0.00119	CcSEcCtD
Metronidazole—Tremor—Capecitabine—colon cancer	0.000523	0.00118	CcSEcCtD
Metronidazole—Stomatitis—Methotrexate—colon cancer	0.000518	0.00117	CcSEcCtD
Metronidazole—Urticaria—Fluorouracil—colon cancer	0.000517	0.00117	CcSEcCtD
Metronidazole—Conjunctivitis—Methotrexate—colon cancer	0.000516	0.00116	CcSEcCtD
Metronidazole—Body temperature increased—Fluorouracil—colon cancer	0.000515	0.00116	CcSEcCtD
Metronidazole—Hypersensitivity—Vincristine—colon cancer	0.000514	0.00116	CcSEcCtD
Metronidazole—Sweating—Methotrexate—colon cancer	0.000509	0.00115	CcSEcCtD
Metronidazole—Malaise—Capecitabine—colon cancer	0.000503	0.00113	CcSEcCtD
Metronidazole—Hepatobiliary disease—Methotrexate—colon cancer	0.000502	0.00113	CcSEcCtD
Metronidazole—Vertigo—Capecitabine—colon cancer	0.000501	0.00113	CcSEcCtD
Metronidazole—Hypersensitivity—Irinotecan—colon cancer	0.000501	0.00113	CcSEcCtD
Metronidazole—Asthenia—Vincristine—colon cancer	0.000501	0.00113	CcSEcCtD
Metronidazole—Syncope—Capecitabine—colon cancer	0.0005	0.00113	CcSEcCtD
Metronidazole—Leukopenia—Capecitabine—colon cancer	0.000499	0.00113	CcSEcCtD
Metronidazole—Agranulocytosis—Methotrexate—colon cancer	0.000496	0.00112	CcSEcCtD
Metronidazole—Palpitations—Capecitabine—colon cancer	0.000493	0.00111	CcSEcCtD
Metronidazole—Loss of consciousness—Capecitabine—colon cancer	0.00049	0.00111	CcSEcCtD
Metronidazole—Asthenia—Irinotecan—colon cancer	0.000488	0.0011	CcSEcCtD
Metronidazole—Hypertension—Capecitabine—colon cancer	0.000481	0.00109	CcSEcCtD
Metronidazole—Hypersensitivity—Fluorouracil—colon cancer	0.00048	0.00108	CcSEcCtD
Metronidazole—Diarrhoea—Vincristine—colon cancer	0.000478	0.00108	CcSEcCtD
Metronidazole—Hepatitis—Methotrexate—colon cancer	0.000477	0.00108	CcSEcCtD
Metronidazole—Arthralgia—Capecitabine—colon cancer	0.000475	0.00107	CcSEcCtD
Metronidazole—Chest pain—Capecitabine—colon cancer	0.000475	0.00107	CcSEcCtD
Metronidazole—Pharyngitis—Methotrexate—colon cancer	0.000473	0.00107	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000472	0.00106	CcSEcCtD
Metronidazole—Diarrhoea—Irinotecan—colon cancer	0.000465	0.00105	CcSEcCtD
Metronidazole—Dry mouth—Capecitabine—colon cancer	0.000464	0.00105	CcSEcCtD
Metronidazole—Dizziness—Vincristine—colon cancer	0.000462	0.00104	CcSEcCtD
Metronidazole—Pruritus—Fluorouracil—colon cancer	0.000461	0.00104	CcSEcCtD
Metronidazole—Visual impairment—Methotrexate—colon cancer	0.00046	0.00104	CcSEcCtD
Metronidazole—Confusional state—Capecitabine—colon cancer	0.000459	0.00104	CcSEcCtD
Metronidazole—Oedema—Capecitabine—colon cancer	0.000455	0.00103	CcSEcCtD
Metronidazole—Infection—Capecitabine—colon cancer	0.000452	0.00102	CcSEcCtD
Metronidazole—Erythema multiforme—Methotrexate—colon cancer	0.000451	0.00102	CcSEcCtD
Metronidazole—Dizziness—Irinotecan—colon cancer	0.00045	0.00101	CcSEcCtD
Metronidazole—Shock—Capecitabine—colon cancer	0.000448	0.00101	CcSEcCtD
Metronidazole—Nervous system disorder—Capecitabine—colon cancer	0.000446	0.00101	CcSEcCtD
Metronidazole—Eye disorder—Methotrexate—colon cancer	0.000446	0.00101	CcSEcCtD
Metronidazole—Diarrhoea—Fluorouracil—colon cancer	0.000446	0.00101	CcSEcCtD
Metronidazole—Thrombocytopenia—Capecitabine—colon cancer	0.000446	0.00101	CcSEcCtD
Metronidazole—Tinnitus—Methotrexate—colon cancer	0.000445	0.001	CcSEcCtD
Metronidazole—Vomiting—Vincristine—colon cancer	0.000444	0.001	CcSEcCtD
Metronidazole—Cardiac disorder—Methotrexate—colon cancer	0.000443	0.000998	CcSEcCtD
Metronidazole—Skin disorder—Capecitabine—colon cancer	0.000442	0.000997	CcSEcCtD
Metronidazole—Rash—Vincristine—colon cancer	0.00044	0.000993	CcSEcCtD
Metronidazole—Hyperhidrosis—Capecitabine—colon cancer	0.00044	0.000992	CcSEcCtD
Metronidazole—Dermatitis—Vincristine—colon cancer	0.00044	0.000992	CcSEcCtD
Metronidazole—Headache—Vincristine—colon cancer	0.000437	0.000987	CcSEcCtD
Metronidazole—Anorexia—Capecitabine—colon cancer	0.000434	0.000978	CcSEcCtD
Metronidazole—Angiopathy—Methotrexate—colon cancer	0.000433	0.000976	CcSEcCtD
Metronidazole—Vomiting—Irinotecan—colon cancer	0.000432	0.000975	CcSEcCtD
Metronidazole—Immune system disorder—Methotrexate—colon cancer	0.000431	0.000971	CcSEcCtD
Metronidazole—Dizziness—Fluorouracil—colon cancer	0.000431	0.000971	CcSEcCtD
Metronidazole—Mediastinal disorder—Methotrexate—colon cancer	0.00043	0.000969	CcSEcCtD
Metronidazole—Rash—Irinotecan—colon cancer	0.000429	0.000967	CcSEcCtD
Metronidazole—Dermatitis—Irinotecan—colon cancer	0.000428	0.000966	CcSEcCtD
Metronidazole—Headache—Irinotecan—colon cancer	0.000426	0.000961	CcSEcCtD
Metronidazole—Mental disorder—Methotrexate—colon cancer	0.000418	0.000942	CcSEcCtD
Metronidazole—Erythema—Methotrexate—colon cancer	0.000415	0.000936	CcSEcCtD
Metronidazole—Nausea—Vincristine—colon cancer	0.000415	0.000935	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000415	0.000935	CcSEcCtD
Metronidazole—Vomiting—Fluorouracil—colon cancer	0.000414	0.000934	CcSEcCtD
Metronidazole—Insomnia—Capecitabine—colon cancer	0.000412	0.000928	CcSEcCtD
Metronidazole—Rash—Fluorouracil—colon cancer	0.000411	0.000926	CcSEcCtD
Metronidazole—Dermatitis—Fluorouracil—colon cancer	0.00041	0.000925	CcSEcCtD
Metronidazole—Paraesthesia—Capecitabine—colon cancer	0.000409	0.000922	CcSEcCtD
Metronidazole—Headache—Fluorouracil—colon cancer	0.000408	0.00092	CcSEcCtD
Metronidazole—Dysgeusia—Methotrexate—colon cancer	0.000407	0.000917	CcSEcCtD
Metronidazole—Nausea—Irinotecan—colon cancer	0.000404	0.000911	CcSEcCtD
Metronidazole—Back pain—Methotrexate—colon cancer	0.000402	0.000906	CcSEcCtD
Metronidazole—Dyspepsia—Capecitabine—colon cancer	0.000401	0.000904	CcSEcCtD
Metronidazole—Decreased appetite—Capecitabine—colon cancer	0.000396	0.000892	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Capecitabine—colon cancer	0.000393	0.000886	CcSEcCtD
Metronidazole—Fatigue—Capecitabine—colon cancer	0.000392	0.000885	CcSEcCtD
Metronidazole—Vision blurred—Methotrexate—colon cancer	0.000391	0.000882	CcSEcCtD
Metronidazole—Pain—Capecitabine—colon cancer	0.000389	0.000878	CcSEcCtD
Metronidazole—Constipation—Capecitabine—colon cancer	0.000389	0.000878	CcSEcCtD
Metronidazole—Nausea—Fluorouracil—colon cancer	0.000387	0.000873	CcSEcCtD
Metronidazole—Feeling abnormal—Capecitabine—colon cancer	0.000375	0.000846	CcSEcCtD
Metronidazole—Malaise—Methotrexate—colon cancer	0.000374	0.000844	CcSEcCtD
Metronidazole—Vertigo—Methotrexate—colon cancer	0.000373	0.000841	CcSEcCtD
Metronidazole—Gastrointestinal pain—Capecitabine—colon cancer	0.000372	0.000839	CcSEcCtD
Metronidazole—Leukopenia—Methotrexate—colon cancer	0.000372	0.000838	CcSEcCtD
Metronidazole—Urticaria—Capecitabine—colon cancer	0.000362	0.000815	CcSEcCtD
Metronidazole—Abdominal pain—Capecitabine—colon cancer	0.00036	0.000811	CcSEcCtD
Metronidazole—Body temperature increased—Capecitabine—colon cancer	0.00036	0.000811	CcSEcCtD
Metronidazole—Convulsion—Methotrexate—colon cancer	0.00036	0.000811	CcSEcCtD
Metronidazole—Chest pain—Methotrexate—colon cancer	0.000353	0.000797	CcSEcCtD
Metronidazole—Arthralgia—Methotrexate—colon cancer	0.000353	0.000797	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000351	0.000792	CcSEcCtD
Metronidazole—Confusional state—Methotrexate—colon cancer	0.000342	0.00077	CcSEcCtD
Metronidazole—Anaphylactic shock—Methotrexate—colon cancer	0.000339	0.000764	CcSEcCtD
Metronidazole—Infection—Methotrexate—colon cancer	0.000337	0.000759	CcSEcCtD
Metronidazole—Hypersensitivity—Capecitabine—colon cancer	0.000335	0.000756	CcSEcCtD
Metronidazole—Nervous system disorder—Methotrexate—colon cancer	0.000332	0.000749	CcSEcCtD
Metronidazole—Thrombocytopenia—Methotrexate—colon cancer	0.000332	0.000748	CcSEcCtD
Metronidazole—Skin disorder—Methotrexate—colon cancer	0.000329	0.000742	CcSEcCtD
Metronidazole—Hyperhidrosis—Methotrexate—colon cancer	0.000328	0.000739	CcSEcCtD
Metronidazole—Asthenia—Capecitabine—colon cancer	0.000327	0.000736	CcSEcCtD
Metronidazole—Anorexia—Methotrexate—colon cancer	0.000323	0.000728	CcSEcCtD
Metronidazole—Pruritus—Capecitabine—colon cancer	0.000322	0.000726	CcSEcCtD
Metronidazole—Diarrhoea—Capecitabine—colon cancer	0.000311	0.000702	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000309	0.000696	CcSEcCtD
Metronidazole—Insomnia—Methotrexate—colon cancer	0.000306	0.000691	CcSEcCtD
Metronidazole—Paraesthesia—Methotrexate—colon cancer	0.000304	0.000686	CcSEcCtD
Metronidazole—Somnolence—Methotrexate—colon cancer	0.000301	0.000679	CcSEcCtD
Metronidazole—Dizziness—Capecitabine—colon cancer	0.000301	0.000679	CcSEcCtD
Metronidazole—Dyspepsia—Methotrexate—colon cancer	0.000298	0.000673	CcSEcCtD
Metronidazole—Decreased appetite—Methotrexate—colon cancer	0.000295	0.000664	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Methotrexate—colon cancer	0.000293	0.00066	CcSEcCtD
Metronidazole—Fatigue—Methotrexate—colon cancer	0.000292	0.000659	CcSEcCtD
Metronidazole—Pain—Methotrexate—colon cancer	0.00029	0.000653	CcSEcCtD
Metronidazole—Vomiting—Capecitabine—colon cancer	0.000289	0.000653	CcSEcCtD
Metronidazole—Rash—Capecitabine—colon cancer	0.000287	0.000647	CcSEcCtD
Metronidazole—Dermatitis—Capecitabine—colon cancer	0.000287	0.000647	CcSEcCtD
Metronidazole—Headache—Capecitabine—colon cancer	0.000285	0.000643	CcSEcCtD
Metronidazole—Feeling abnormal—Methotrexate—colon cancer	0.000279	0.00063	CcSEcCtD
Metronidazole—Gastrointestinal pain—Methotrexate—colon cancer	0.000277	0.000625	CcSEcCtD
Metronidazole—Nausea—Capecitabine—colon cancer	0.00027	0.00061	CcSEcCtD
Metronidazole—Urticaria—Methotrexate—colon cancer	0.000269	0.000607	CcSEcCtD
Metronidazole—Abdominal pain—Methotrexate—colon cancer	0.000268	0.000604	CcSEcCtD
Metronidazole—Body temperature increased—Methotrexate—colon cancer	0.000268	0.000604	CcSEcCtD
Metronidazole—Hypersensitivity—Methotrexate—colon cancer	0.00025	0.000563	CcSEcCtD
Metronidazole—Asthenia—Methotrexate—colon cancer	0.000243	0.000548	CcSEcCtD
Metronidazole—Pruritus—Methotrexate—colon cancer	0.00024	0.000541	CcSEcCtD
Metronidazole—Diarrhoea—Methotrexate—colon cancer	0.000232	0.000523	CcSEcCtD
Metronidazole—Dizziness—Methotrexate—colon cancer	0.000224	0.000505	CcSEcCtD
Metronidazole—Vomiting—Methotrexate—colon cancer	0.000215	0.000486	CcSEcCtD
Metronidazole—Rash—Methotrexate—colon cancer	0.000214	0.000482	CcSEcCtD
Metronidazole—Dermatitis—Methotrexate—colon cancer	0.000213	0.000481	CcSEcCtD
Metronidazole—Headache—Methotrexate—colon cancer	0.000212	0.000479	CcSEcCtD
Metronidazole—Nausea—Methotrexate—colon cancer	0.000201	0.000454	CcSEcCtD
